0

Brivudine Impurity 13

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAPB74131069
CAS74131-06-9
Synonyms(Z)-4-(1-((2R,4R,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)but-3-enoic acid
Molecular Weight312.28
Molecular FormulaC13H16N2O7

What is the CAS number for Brivudine Impurity 13?

The CAS number for Brivudine Impurity 13 is 74131-06-9.

What is the synonym for Brivudine Impurity 13?

The synonym for Brivudine Impurity 13 is (Z)-4-(1-((2R,4R,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)but-3-enoic acid.

What is the molecular weight of Brivudine Impurity 13?

The molecular weight of Brivudine Impurity 13 is 312.28.

What is the molecular formula of Brivudine Impurity 13?

The molecular formula of Brivudine Impurity 13 is C13H16N2O7.

Can Brivudine Impurity 13 be used as an active pharmaceutical ingredient (API)?

No, Brivudine Impurity 13 is not typically used as an active pharmaceutical ingredient (API), but rather it is an impurity that needs to be controlled in pharmaceutical formulations.

Is Brivudine Impurity 13 a naturally occurring substance?

Brivudine Impurity 13 is a synthetic compound and not a naturally occurring substance.

Are there any specific safety considerations or hazards associated with handling Brivudine Impurity 13?

It is important to follow proper safety protocols when handling Brivudine Impurity 13, as with any chemical substance.

What is the potential use of Brivudine Impurity 13 in pharmaceutical research?

Brivudine Impurity 13 may be used in pharmaceutical research as a reference standard or for analytical purposes to ensure the quality and purity of Brivudine formulations.

How is Brivudine Impurity 13 typically identified and quantified in pharmaceutical formulations?

Brivudine Impurity 13 can be identified and quantified using analytical techniques such as HPLC (High Performance Liquid Chromatography) or mass spectrometry.

Are there any regulations or guidelines that specify acceptable levels of Brivudine Impurity 13 in pharmaceutical products?

Yes, regulatory authorities such as the FDA (Food and Drug Administration) may have established limits on the allowable levels of Brivudine Impurity 13 in pharmaceutical products to ensure patient safety and efficacy.

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode